Cancer Family
Soft Tissue Neoplasm
CI-CAN-00000354Explore in graph →
Non-malignant441 active trials9 approved drugs183 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000354Explore in graph →
Clinical trials
2,078 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03916575 | PEComas: Natural History and Prognostic Factors(PEComas) | unknown | — | 60 | University Hospital, Strasbourg, FranceOTHER | 1 | May 1, 2019 | clinicaltrials |
| NCT02914704 | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | unknown | N/A | 500 | Turku University HospitalOTHER_GOV | 1 | Apr 29, 2019 | clinicaltrials |
| NCT03904368 | The Value of Myomectomy in Women With Intramural Myoma Before IVF. | unknown | N/A | 100 | Cairo UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT03874273 | Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors | unknown | Phase 2 / Phase 3 | 25 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT03862768 | Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment | unknown | N/A | 92 | Shanghai Zhongshan HospitalOTHER | 0 | Mar 5, 2019 | clinicaltrials |
| NCT03792009 | Paracervical Block in Laparoscopic Hysterectomy(PALAPA) | unknown | N/A | 86 | Kangbuk Samsung HospitalOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT01337401 | A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)(CASPS) | unknown | Phase 2 | 36 | Institute of Cancer Research, United KingdomOTHER | 3 | Jan 24, 2019 | clinicaltrials |
| NCT03792542 | Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy | unknown | Phase 2 | 44 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03219671 | Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS) | unknown | Phase 2 | 20 | Alona ZerOTHER | 1 | Dec 26, 2018 | clinicaltrials |
| NCT03784976 | Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis | unknown | N/A | 90 | University of Illinois at Urbana-ChampaignOTHER | 1 | Dec 24, 2018 | clinicaltrials |
| NCT02942537 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1) | unknown | Phase 2 / Phase 3 | 36 | Karolinska InstitutetOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03680430 | Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas(ADAPTO-SARC) | unknown | N/A | 61 | Institut Paoli-CalmettesOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT01807468 | Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors | unknown | Phase 2 | 12 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | unknown | Phase 2 | 41 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03092128 | A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment | unknown | — | 200 | Xueding WangOTHER | 1 | Sep 13, 2018 | clinicaltrials |
| NCT03586947 | Association Between Vitamin D and the Risk of Uterine Fibroids(ABVDATROUF) | unknown | N/A | 1,160 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT03601234 | Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors(LECSINGST) | unknown | N/A | 80 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03550703 | Open Label Immunotherapy of Myoma(V3-myoma) | unknown | Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Jul 6, 2018 | clinicaltrials |
| NCT02983539 | Detection of Circulating Tumor Cells in Patients With Sarcomas(CTCS) | unknown | — | 20 | AC Camargo Cancer CenterOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03509168 | The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.(MM) | unknown | Phase 2 / Phase 3 | 46 | Makerere UniversityOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT03500367 | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | unknown | Phase 4 | 25 | Peking Union Medical College HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02336724 | A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor | unknown | Phase 2 | 88 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02610985 | 2-D and 3-D Laparoscopic Hysterectomy | unknown | N/A | 400 | Zealand University HospitalOTHER | 1 | Apr 3, 2018 | clinicaltrials |
| NCT03219385 | Directed Ablation of Uterine Fibroids Using a Noninvasive Approach(DIANA) | unknown | N/A | 180 | Mirabilis Medica, Inc.INDUSTRY | 0 | Mar 21, 2018 | clinicaltrials |
| NCT03450421 | Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy | unknown | N/A | 152 | Actamax Surgical Materials LLCINDUSTRY | 0 | Mar 1, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT02763748 | the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor | unknown | N/A | 120 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT02982486 | A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | unknown | Phase 2 | 60 | Assaf-Harofeh Medical CenterOTHER_GOV | 0 | Nov 1, 2017 | clinicaltrials |
| NCT03096912 | A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | unknown | Phase 2 | 30 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Oct 25, 2017 | clinicaltrials |
| NCT02834169 | French National Registry of Rare Peritoneal Surface Malignancies(RENAPE) | unknown | — | 2,171 | Hospices Civils de LyonOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT03122782 | Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy | unknown | Phase 3 | 80 | Ain Shams UniversityOTHER | 0 | Jun 29, 2017 | clinicaltrials |
| NCT03171389 | POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST(POETIG) | unknown | Phase 2 | 81 | Sebastian BauerOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03121846 | Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy | unknown | Phase 2 | 80 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 22, 2017 | clinicaltrials |
| NCT03082079 | Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm) | unknown | N/A | 90 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | May 16, 2017 | clinicaltrials |
| NCT02449343 | Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) | unknown | Phase 2 / Phase 3 | 233 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02441972 | Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics | unknown | Phase 1 | 200 | Wuxi No. 4 People's HospitalOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT03064243 | A Phase II Study of Apatinib in STS Patients | unknown | Phase 2 | 53 | Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER | 0 | Feb 27, 2017 | clinicaltrials |
| NCT02443948 | Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST) | unknown | — | 60 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03000114 | Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease | unknown | Phase 4 | 334 | University of CalgaryOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT02571829 | A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | unknown | Phase 2 | 30 | Hadassah Medical OrganizationOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02086344 | Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy | unknown | N/A | 167 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02357563 | Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation | unknown | Phase 4 | 110 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02361879 | Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma | unknown | Phase 4 | 146 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02361905 | Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas | unknown | Phase 4 | 42 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02288130 | Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy(MYOMEX) | unknown | Phase 4 | 100 | Amsterdam UMC, location VUmcOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT02931981 | Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor | unknown | — | 50 | RenJi HospitalOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT02895633 | Osteoarticular Tumor Characterization by Advanced Imaging(TUMOSTEO) | unknown | N/A | 1,090 | Central Hospital, Nancy, FranceOTHER | 1 | Sep 12, 2016 | clinicaltrials |
| NCT02884960 | Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization | unknown | N/A | 118 | Gary Siskin, MDOTHER | 0 | Sep 1, 2016 | clinicaltrials |
| NCT02866045 | EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs | unknown | Phase 3 | 104 | Unity Health TorontoOTHER | 1 | Aug 15, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
Data updated 23 days agoSource updated May 1, 2019source: clinicaltrials